In breast cancer, several studies have suggested that moderate to high COX-2 expression is related to the genesis of mammary tumors and the expression level is associated with the aggressiveness of breast cancer, including large tumor size, positive axillary lymph node metastases, and HER2-positive tumor status [9–11]. Here, ERBB2 is linked to breast carcinoma.